Cell Signaling Technology

PATL1/PAT1b (D8P1B) Rabbit Monoclonal Antibody

#14288 · $161,351

56
Citing papers
1.5k
Combined citations
Supplier page Find this product

Research areas

Histone Deacetylase Inhibitors Research7Heart Failure Treatment and Management5Ubiquitin and proteasome pathways4Peptidase Inhibition and Analysis4Cancer Cells and Metastasis4Autophagy in Disease and Therapy4Protein Degradation and Inhibitors4Hearing, Cochlea, Tinnitus, Genetics3

Papers citing this product

1
Synthetic RNA–protein modules integrated with native translation mechanisms to control gene expression in malaria parasites
Nature Communications·2016·226 cit.·DOI
2
Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology
Nature Neuroscience·2021·169 cit.·DOI
3
Mitochondrial Localization of ABC Transporter ABCG2 and Its Function in 5-Aminolevulinic Acid-Mediated Protoporphyrin IX Accumulation
PLoS ONE·2012·136 cit.·DOI
4
An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene
PLoS ONE·2012·122 cit.·DOI
5
Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase
Journal of Oncology·2019·72 cit.·DOI
6
A novel loss-of-function mutation in Npr2 clarifies primary role in female reproduction and reveals a potential therapy for acromesomelic dysplasia, Maroteaux type
Human Molecular Genetics·2012·69 cit.·DOI
7
Autophagy activation promotes bevacizumab resistance in glioblastoma by suppressing Akt/mTOR signaling pathway
Oncology Letters·2017·63 cit.·DOI
8
Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer
Journal of Medicinal Chemistry·2023·50 cit.·DOI
9
Transforming growth factor-β receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells
Biochemical Journal·2005·41 cit.·DOI
10
The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells <i>via</i> hCNT1 transporter and multidrug-resistance associated protein MRP-2
Oncotarget·2015·41 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.